Skip to main content
Premium Trial:

Request an Annual Quote

Fisher Scientific Products and Services Revenue Jumps 42 Percent in Third Quarter

NEW YORK, Nov. 4 (GenomeWeb News) - Fisher Scientific today said that third-quarter revenues increased 42 percent, which includes a 50-percent rise in revenue from scientific products and services.

Fisher Scientific's third-quarter revenues swelled to $1.2 billion from $890 million in the third quarter of 2003. Revenues from scientific products and services rose to $945 million from $632 million year over year.


Sales of scientific products and services in the recent quarter totaled $922.8 million, an increase of 46 percent compared to the third quarter of 2003.


Apogent and Oxoid, the company's molecular biology-supply unit, and Dharmacon, a recent acquisition, contributed revenue to Fisher's scientific products and services income. However, the Hampton, NH-based firm did not break out revenues by unit.


Net income dropped to $10.8 million, or $.10 per diluted share, from $27.7 million, or $.47 per share, year over year.


Fisher reported $296.4 million in cash and cash equivalents available on Sept. 30, part of the company's $7.9 billion of total assets.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.